Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor

Details for Australian Patent Application No. 2004229376 (hide)

Owner Genentech, Inc.

Inventors Benyunes, Mark

Agent Griffith Hack

Pub. Number AU-B-2004229376

PCT Pub. Number WO2004/091657

Priority 60/461,481 09.04.03 US

Filing date 6 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 13 December 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091657 Priority application(s): WO2004/091657

13 December 2007 Application Accepted

  Published as AU-B-2004229376

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229378-Embolic occlusion of uterine arteries

2004229368-Hermetically sealed product and related methods of manufacture